Quality of life and sexual health after pelvic exenteration for gynecologic cancer
Looks at quality of life and sexuality in women after pelvic exenteration surgery.
Plain-language title generated from the registry record
Registry title: Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
Key facts
- Where
- Tampere, FinlandSee the site
Where in Finland
- Tampere University HospitalTampere, FinlandNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Tampere University Hospital
- Trial code
- NCT07594327
- Record updated
- 22 May 2026
- Original description
Pelvic exenteration is an exceptionally extensive and very rare surgical procedure, most commonly used in the treatment of locally recurrent cervical cancer among gynecological malignancies. It is typically performed with curative intent when no other treatment options remain feasible.Read full original descriptionShow less
Pelvic Exenteration as a Curative Option in Recurrent Gynecological Cancer: Oncological Outcomes and Impact on Quality of Life and Sexuality
Pelvic exenteration is an exceptionally extensive and very rare surgical procedure, most commonly used in the treatment of locally recurrent cervical cancer among gynecological malignancies. It is typically performed with curative intent when no other treatment options remain feasible.
The aim of this study is to examine the quality of life and sexuality of patients who have undergone pelvic exenteration.
This observational cross-sectional study utilizes internationally validated questionnaires assessing quality of life and sexual function: EORTC QLQ-C30, EORTC QLQ-CX24, and PISQ-12.
The findings of this study will provide important guidance for the selection and planning of pelvic exenteration. Improved understanding of postoperative quality of life will support patient selection and enable more comprehensive and individualized patient counseling.
Inclusion: patient age over 18 years; a diagnosis of gynecologic cancer; having undergone exenteration surgery on or after January 1, 2000 (at least 6 months prior); the ability to read and write Finnish.
Exclusion: cognitive and/or neurological disease that affects physical functioning and may therefore influence sexual functioning or make it difficult to respond to the questionnaire.